EXECUTIVE INSIGHTS
DOMAIN EXPERTS
PLAYERS
PARTICIPANTS
-
JUL 2024
-
EDITION 20
-
TABLES 202
-
REGIONS 26
-
SEGMENTS 7
-
PAGES 299
-
US$ 5450
-
MCP-6811
-
JOIN OUR PANEL
EXECUTIVE ENGAGEMENTS BY TIER
-
CXO
-
VICE PRESIDENT
-
DIRECTOR
-
MANAGER
-
MARKETING
© Copy rights Global Industry Analysts, Inc., USA. www.strategyr.com All Rights Reserved.
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
Global Next Generation Sequencers Market to Reach US$43.3 Billion by 2030
The global market for Next Generation Sequencers estimated at US$14.1 Billion in the year 2023, is expected to reach US$43.3 Billion by 2030, growing at a CAGR of 17.4% over the analysis period 2023-2030. Consumables, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$26.6 Billion by the end of the analysis period. Growth in the Platforms segment is estimated at 16.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 22.9% CAGR
The Next Generation Sequencers market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.0 Billion by the year 2030 trailing a CAGR of 22.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.2% and 15.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.
Global Next Generation Sequencers Market - Key Trends and Drivers Summarized
Next-Generation Sequencing (NGS) technologies, initiated in 2005, have revolutionized the field of genetics by allowing for the simultaneous sequencing of multiple DNA strands, a significant advancement over the traditional Sanger sequencing. This technology, originally dubbed "massively-parallel sequencing," offers unprecedented speed and reduced costs, making extensive genomic studies more accessible. While Sanger sequencing is still utilized for smaller projects or to validate NGS results due to its high accuracy, NGS excels in efficiency and scalability, analyzing hundreds to thousands of genes across various samples in a single run. NGS detects a wide range of genomic features from single nucleotide variants to complex structural variations and RNA fusions, facilitating extensive genetic analyses that were previously unfeasible.
NGS stands out not just for its volume handling but also for its lower sample requirements, higher accuracy, and the ability to detect rare genetic variants. These attributes make it an essential tool in diverse fields such as medicine, agriculture, and environmental science, advancing genomic research, clinical diagnostics, and forensic investigations. The NGS process is intricate, beginning with the construction of a sequencing library where DNA or cDNA samples are fragmented and linked to unique molecular adaptors for easy identification. This is followed by clonal amplification of the DNA fragments on a solid surface to enhance signal detection during sequencing, using technologies that employ a `sequencing by synthesis` approach. Instruments involved in this process detect each nucleotide addition either through optical signals or, as in Ion Torrent technology, electrical signals produced by hydrogen ions released during DNA synthesis. The data analysis phase is complex, involving multiple stages of interpretation to transform raw sequencing data into valuable genetic insights.
The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.
SELECT PLAYERS
Agilent Technologies, Inc.; Becton, Dickinson and Company; Fluidigm Corporation; Illumina Inc.; Oxford Gene Technology; Oxford Nanopore Technologies; Pacific Biosciences of California Inc.; QIAGEN N.V.; RainDance Technologies Inc.; Roche Sequencing; Thermo Fischer Scientific Inc.
SEGMENTS
» Product (Consumables, Platforms, Services) » End-Use (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
Global EconomicUpdate |
Next Generation Sequencers – Global Key Competitors Percentage Market Share in 2024 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 93 Players Worldwide in 2024 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Advancements in Sequencing Technologies Expand Addressable Market Opportunity |
Increased Adoption in Clinical Diagnostics Throws the Spotlight on Sequencing Applications |
Rising Demand for Personalized Medicine Drives Adoption of NGS |
Integration with Artificial Intelligence and Big Data Analytics Generates New Opportunities |
Technological Innovations in Sample Preparation and Library Construction Spur Growth |
Growing Utilization in Oncology Research Expands Market Potential |
Emergence of Single-Cell Sequencing Drives Adoption of Advanced NGS Technologies |
Focus on Rare Disease Diagnostics Generates Demand for High-Throughput Sequencing |
Development of Portable and Real-Time Sequencing Devices Expands Addressable Market |
Rising Investments in Genomic Research Strengthens Market Demand |
Adoption of NGS in Infectious Disease Surveillance Generates New Opportunities |
Consumer Demand for Ancestry and Genetic Testing Drives Market Adoption |
Integration with CRISPR and Gene Editing Technologies Generates Demand for NGS |
Focus on Precision Medicine and Targeted Therapies Strengthens Business Case for NGS |
Emerging Applications in Microbiome Research Propel Growth in NGS Utilization |
Challenges in Regulatory Compliance and Quality Control |
4. GLOBAL MARKET PERSPECTIVE |
World Next Generation Sequencers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E) |
USA Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
USA Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
JAPAN |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E) |
Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
CHINA |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E) |
China Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
China Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
EUROPE |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E) |
Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
Europe Historic Review for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
FRANCE |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E) |
France Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
France Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
GERMANY |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E) |
Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
UNITED KINGDOM |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E) |
UK Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
UK Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Spain Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Spain 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Spain Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Spain 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Russia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Russia 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Russia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Russia 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ASIA-PACIFIC |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
AUSTRALIA |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E) |
Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Australia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Australia 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Australia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Australia 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
INDIA |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E) |
India Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
India Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
India 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
India Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
India Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
India 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
South Korea Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
South Korea 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
South Korea Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
South Korea 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
LATIN AMERICA |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E) |
Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030 |
Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ARGENTINA |
Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Argentina Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Argentina 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Argentina Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Argentina 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
BRAZIL |
Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Brazil Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Brazil 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Brazil Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Brazil 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
MEXICO |
Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Mexico Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Mexico 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Mexico Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Mexico 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF LATIN AMERICA |
Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Latin America 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Latin America 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
MIDDLE EAST |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E) |
Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030 |
Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
IRAN |
Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Iran Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Iran 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Iran Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Iran 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ISRAEL |
Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Israel Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Israel 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Israel Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Israel 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
SAUDI ARABIA |
Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Saudi Arabia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Saudi Arabia 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Saudi Arabia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Saudi Arabia 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
UNITED ARAB EMIRATES |
UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UAE Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UAE 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UAE Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UAE 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF MIDDLE EAST |
Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Middle East 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Middle East 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
AFRICA |
Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E) |
Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Africa Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Africa 16-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2014, 2024 & 2030 |
Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Africa Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Africa 16-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.